Optetrak 244-23-13Recalls & reported problems
Exactech, Inc. · Class 2 · Implant
All models of Optetrak (336)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10885862064011), received between Sep 9, 2022 and Aug 12, 2024 — classified as 6 injuries.
The most frequently reported specific device problem is “Naturally Worn” (6 reports).
1 FDA recall record name this device's identifier, 1 still open.
3 other recalls cover devices cleared under the same FDA submission (K033883); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Aug 30, 2021Open, Classified
Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.
Z-0019-2022 · Root cause: Process control · Recall details · FDA record ↗
Most reported problems
Device problems
- Naturally Worn6
- Unstable3
- Adverse Event Without Identified Device or Use Problem2
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Failure of Implant4
- Pain3
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available2
- Joint Laxity2
- Scar Tissue2
- Ambulation or Postural Difficulties1
- Bone Fracture(s)1
- Discomfort1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryAug 12, 2024Unstable; Naturally Worn; Unstable; Naturally Worn
IT WAS REPORTED THAT APPROXIMATELY 20 MONTHS AFTER A RIGHT KNEE REPLACEMENT PROCEDURE, THE PATIENT MAY REQUIRE A REVISION PROCEDURE TO ADDRESS PROSTHESIS WEAR AND INSTABILITY. NO FURTHER ISSUES OR COMPLICATIONS WERE REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 19961082 ↗InjuryMay 8, 2024Naturally Worn; Naturally Worn
IT WAS REPORTED THAT APPROXIMATELY 181 MONTHS AFTER A LEFT TOTAL KNEE REPLACEMENT PROCEDURE, THE PATIENT UNDERWENT A REVISION PROCEDURE TO ADDRESS POLYETHYLENE WEAR, PAIN AND BONE FRACTURE. NO FURTHER ISSUES OR COMPLICATIONS WERE REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Bone Fracture(s); Failure of Implant; Implant Pain; Pain; Scar Tissue
MAUDE report 19267502 ↗InjuryNov 9, 2023Naturally Worn; Naturally Worn
IT WAS REPORTED THAT THIS FEMALE PATIENT WAS REVISED FOR A THIRD TIME IN (B)(6) 2021 (1ST REVISION: CASE-(B)(4) / 1038671-2023-02731, 2ND REVISION: CASE-(B)(4) / 1038671-2023-02728). POLYETHYLENE IS OBSERVED WITH WEAR IN THE MEDIAL AREA AND IN THE CENTRAL PIVOT, WITH MEDIAL AND POSTEROLATERAL DELAMINATION. REVISED TO A COMPETITOR DEVICE.
Patient problems: Failure of Implant; Insufficient Information
MAUDE report 18103795 ↗InjuryNov 10, 2022Unstable; Naturally Worn; Adverse Event Without Identified Device or Use Problem; Loosening of Implant Not Related to Bone-Ingrowth; Unstable; Naturally Worn; Adverse Event Without Identified Device or Use Problem; Loosening of Implant Not Related to Bone-Ingrowth
IT WAS REPORTED VIA A LEGAL NOTIFICATION THAT A MALE PATIENT, INITIAL RIGHT KNEE IMPLANTED ON (B)(6) 2013, DUE TO OSTEOARTHRITIS, UNDERWENT A REVISION PROCEDURE ON (B)(6) 2021, APPROXIMATELY 8 YEARS 6 MONTHS POST THE INITIAL IMPLANT PROCEDURE DUE TO A FAILED RIGHT TOTAL KNEE ARTHROPLASTY WITH SEVERE PROXIMAL TIBIAL BONE LOSS SECONDARY TO OSTEOLYSIS. THE SURGEON¿S DICTATED INTRAOPERATIVE FINDINGS INDICATED THAT THERE WAS COPIOUS FIBRINOUS SCAR TISSUE HEMOSIDERIN STAINED SYNOVITIS, "AND"...SEGMENTED BONE LOSS FROM THE PROXIMAL TIBIA WAS NOTED FROM THE MEDICAL ASPECT OF THE TIBIAL TUBERCLE GOING AROUND COUNTER-CLOCKWISE TO THE LATERAL ASPECT OF THE TIBIAL TUBERCLE. FOLLOWING THE REVISION SURGERY, PLAINTIFF CONTINUES TO BE LIMITED IN HIS ACTIVITIES OF DAILY LIVING, AND EXPERIENCES DAILY PAIN AND DISCOMFORT IN HIS RIGHT KNEE WHICH LIMITS HIS ACTIVITIES AND IMPACTS HIS QUALITY OF LIFE. NO ADDITIONAL INFORMATION.
Patient problems: Ambulation or Postural Difficulties; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Discomfort; Joint Laxity; Osteolysis; Osteopenia/ Osteoporosis; Pain; Scar Tissue; Synovitis
MAUDE report 15770149 ↗InjuryOct 5, 2022Naturally Worn; Naturally Worn
AS REPORTED, THE PATIENT HAD AN INITIAL LEFT TKA ON (B)(6) 2012. THE PATIENT WAS REVISED ON (B)(6) 2014, DUE TO PREMATURE POLYETHYLENE WEAR OF THE TIBIAL INSERT, CAUSING LOOSE COMPONENTS AND OSTEOLYSIS. NO OTHER INFORMATION REPORTED.
Patient problems: Failure of Implant
MAUDE report 15543692 ↗InjurySep 9, 2022Unstable; Naturally Worn; Adverse Event Without Identified Device or Use Problem; Unstable; Naturally Worn; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED VIA A LEGAL TOLLING AGREEMENT, THAT A FEMALE PATIENT, INITIAL RIGHT KNEE IMPLANTED ON (B)(6) 2008, UNDERWENT A REVISION PROCEDURE ON (B)(6) 2022, APPROXIMATELY 14 YEARS POST THE INITIAL IMPLANT PROCEDURE FOR UNKNOWN REASONS. NO ADDITIONAL INFORMATION IS AVAILABLE. BASED ON REVIEW OF ALL AVAILABLE INFORMATION, THERE IS NO EVIDENCE TO SUGGEST THAT THE REPORTED EVENT IS RELATED TO ANY DESIGN OR MANUFACTURING ISSUES. THE CAUSE OF THE SUBSEQUENT REVISION CANNOT BE CONCLUSIVELY DETERMINED, INSUFFICIENT INFORMATION.
Patient problems: Failure of Implant; Joint Impingement; Joint Laxity; No Clinical Signs, Symptoms or Conditions; Pain
MAUDE report 15394599 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K033883. One submission often covers many models, so check the product and lot details in each record.
- Z-0584-2024 · Nov 21, 2023 · Open, ClassifiedExactech Optetrak Logic PS Knee System, Catalog Numbers: 02-012-35-5009
- Z-0021-2022 · Aug 30, 2021 · Open, ClassifiedOPTETRAK LOGIC Polyethylene Tibial Inserts, labeled as the following: a. OPTETRAK Logic PS Tibial Inserts, Product Line 02-012-35-XXXX; b. OPTETRAK Logic PSC Tibial Inser
- Z-0906-2015 · Oct 9, 2014 · TerminatedOptetrak Asymmetric Hi-Flex Posterior Stabilized Cemented Femorals, size 3, Catalog #244-02-03, Catalog #244-03-03. Usage:Femoral implants
Other Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices
- ATTUNE 1506-00-005Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER589 reports
- ATTUNE 1506-00-004Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER580 reports
- JOURNEY 74012812Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER502 reports
- JOURNEY 74011856Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER438 reports
- PERSONA™ 42-5099-094-00Zimmer, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER406 reports
- JOURNEY 74011857Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER388 reports
- ATTUNE 1506-00-007Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER288 reports
- ATTUNE 1506-00-003Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER271 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page